These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1456 related items for PubMed ID: 18457835
21. Cloning and expression of Toxoplasma gondii dense granular protein 4 (GRA4) in Pichia pastoris. Lau YL, Hasan MT, Thiruvengadam G, Idris MM, Init I. Trop Biomed; 2010 Dec; 27(3):525-33. PubMed ID: 21399595 [Abstract] [Full Text] [Related]
22. Preparation of Toxoplasma gondii RH strain antigen, antigen analysis and antigen detection in sera: a review. Susanto L, Muljono R. Southeast Asian J Trop Med Public Health; 2001 Dec; 32 Suppl 2():195-201. PubMed ID: 12041589 [Abstract] [Full Text] [Related]
27. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1. Mishima M, Xuan X, Shioda A, Omata Y, Fujisaki K, Nagasawa H, Mikami T. J Vet Med Sci; 2001 Apr; 63(4):433-8. PubMed ID: 11346179 [Abstract] [Full Text] [Related]
32. [Reactivity of antigenic fractions obtained from Toxoplasma gondii evaluated with Western blotting]. Zotti C, Maiello A, Moiraghi Ruggenini A, Sacco T, Parusso R, Ferrero C, Barale A. Boll Ist Sieroter Milan; 1989 Apr; 68(2):167-73. PubMed ID: 2491301 [Abstract] [Full Text] [Related]
33. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals]. Piergili Fioretti D. Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712 [Abstract] [Full Text] [Related]
34. Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge. Shang L, Liu Q, Liu W, Men J, Gao S, Jiang L, Wang Z, Zhai Y, Jin H, Lian H, Chen C, Xia Z, Yuan Z, Zhu XQ. Vaccine; 2009 May 11; 27(21):2741-5. PubMed ID: 19428887 [Abstract] [Full Text] [Related]
37. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Dlugonska H. Exp Parasitol; 2009 Sep 11; 123(1):81-9. PubMed ID: 19508869 [Abstract] [Full Text] [Related]
38. [High efficiency expression and antigenicity analysis of the SAG2 gene from Toxoplasma gondii RH strain]. Lei MJ, Wu ST, Dai WX, Pan HR, Lin QP, Wen JX, Huang DN, Gao ST, Zhang RL. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Aug 11; 22(4):231-4. PubMed ID: 15587158 [Abstract] [Full Text] [Related]
39. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Wang H, He S, Yao Y, Cong H, Zhao H, Li T, Zhu XQ. Exp Parasitol; 2009 Jul 11; 122(3):226-32. PubMed ID: 19366622 [Abstract] [Full Text] [Related]
40. Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies. Kato M, Claveria FG, Maki Y, Sanda K, Tanaka T, Omata Y, Nagasawa H, Suzuki N. Pathobiology; 2007 Jul 11; 74(1):50-6. PubMed ID: 17496433 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]